G. Shan

[Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].

Zhenxin Zhang, Xinde Wang, Qingtang Chen, 2002, Zhonghua yi xue za zhi.

Effect on thromboprophylaxis among hospitalized patients using a system-wide multifaceted quality improvement intervention: Rationale and design for a multicenter cluster randomized clinical trial in China

G. Shan, Z. Zhang, Z. Zhai, 2020, American Heart Journal.

Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer’s Disease Task Force

J. Cummings, P. Aisen, B. Vellas, 2018, The Journal of Prevention of Alzheimer's Disease.